JACOB MICHELSEN: Open Payments
NPI 1841803533 · CALDWELL, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 34 payments from 19 companies in 2025. Trend: 2023 $106 · 2024 $564 · 2025 $717
Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $89 |
| ABBVIE INC. | 3 | $84 |
| Exact Sciences Corporation | 2 | $63 |
| Lilly USA, LLC | 3 | $54 |
| Astellas Pharma US Inc | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Corcept Therapeutics | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Viatris Specialty LLC | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
Products named: UBRELVY, Ozempic, MOUNJARO, Veozah, REXULTI, Korlym, YUPELRI, Cologuard Collection Kit.
Industry payments across ID — which companies pay providers there.
